| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |